News

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...
A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains ...
For some leukemia patients, each hour of delayed care can be the difference between life and death. JHU's Eugene Shenderov is developing an AI algorithm to help doctors reach faster diagnoses.
RAPID-CRISPR test quickly and accurately diagnoses acute promyelocytic leukemia, a rare and aggressive blood cancer, with ...
Chromosomal translocations of transcription factors generating fusion proteins with aberrant transcriptional activity are common in acute leukemia. In acute promyelocytic leukemia (APL), the ...
for the treatment of acute promyelocytic leukemia (APL), a blood cancer that once had a high fatality rate. The invention and use of oral-ATO is of historic importance for medicine in Hong Kong.
Betty Lester was a dedicated wife to her husband Wayne of 67 years. She was a loving mother and grand mother. She loved spending time with her family.
Human PBMCs, mucosal associated invariant T cells, AML (acute myelogenous leukemia), APL (acute promyelocytic leukemia), and myeloma cells, as well as lymph node and bone marrow cells. Tissue-derived ...
Pagano was diagnosed with acute promyelocytic leukemia in 2012 when he was the head coach of the Indianapolis Colts. The money goes to the Simon Comprehensive Cancer Center at Indiana University.
StockNews.com started coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Free Report) in a research note released on Sunday morning. The brokerage issued a sell rating on the stock. Syros ...